Fig. 1: Overall survival outcomes and prognostic factors in angiosarcoma.
From: Clinical implications of systemic and local immune responses in human angiosarcoma
a In the overall cohort (n = 150), 50.8% of the patients were alive at 1 year. Median OS was 1.1 year. b Independent predictors of OS at the time of diagnosis include the presence of distant metastasis, age >65 years, and poor performance status (ECOG 1–4).
